首页> 外国专利> COMBINATION THERAPY OF SUBSTANCE-P FOR MOBILIZATION OF HEMATOPOIETIC STEM CELLS

COMBINATION THERAPY OF SUBSTANCE-P FOR MOBILIZATION OF HEMATOPOIETIC STEM CELLS

机译:物质-P动员造血干细胞的组合治疗

摘要

The present invention relates to: a combination therapy and a combination product that are for the mobilization of a large amount of hematopoietic stem cells in blood and include substance-P and AMD3100 or a pharmaceutically acceptable salt thereof; a method for collecting a large amount of mobilized hematopoietic stem cells, the method comprising a step for isolating a blood fraction containing the mobilized hematopoietic stem cells from peripheral blood obtained from an individual sequentially administered with substance P and AMD3100 or a pharmaceutically acceptable salt thereof; and a use of a combined product containing substance P and AMD3100 or a pharmaceutically acceptable salt thereof for the mobilization of a large amount of hematopoietic stem cells in blood.
机译:本发明涉及:组合疗法和用于动员血液中大量造血干细胞的组合产物,包括物质-P和AMD3100或其药学上可接受的盐; 一种用于收集大量动员的造血干细胞的方法,该方法包括将含有从由依次施用的个体的个体的外周血和amd3100或其药学上可接受的盐分离从含有的外周血中分离含有动员的造血干细胞的步骤。 并使用含有物质P和AMD3100的组合产物或其药学上可接受的盐,用于动员血液中大量的造血干细胞。

著录项

  • 公开/公告号WO2022014985A1

    专利类型

  • 公开/公告日2022-01-20

    原文格式PDF

  • 申请/专利权人 ELPHIS CELL THERAPEUTICS;

    申请/专利号WO2021KR08882

  • 申请日2021-07-12

  • 分类号A61K38/04;A61K31/395;A61P43;C12N5/0789;A61M1/02;A61M1/34;

  • 国家 KR

  • 入库时间 2022-08-24 23:29:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号